Literature DB >> 23059888

Expression and localization of VEGF receptors in human fetal skeletal tissues.

M Marini1, E Sarchielli, M Toce, A Acocella, R Bertolai, C Ciulli, C Orlando, E Sgambati, G B Vannelli.   

Abstract

During development the vertebrate skeleton is the product of deriving cells from distinct embryonic lineages. The craniofacial skeleton is formed by migrating cranial neural crest cells, whereas the axial and limb skeletons are derived from mesodermal cells. The Vascular Endothelial Growth Factors (VEGFs) / receptors (VEGFRs) system plays an important role in angiogenesis, as well as osteogenesis, during bone development, growth, and remodeling, attracting endothelial cells and osteoclasts and stimulating osteoblast differentiation. Recent evidence has shown that during development VEGFR-3 is also expressed in neural and glial precursors of forebrain and cerebellum, as well as in the eye. In this study, we found that VEGFR-1, VEGFR-2 and VEGFR-3 are expressed in human bone both in fetal and adult life. The gene expression levels were significantly higher in fetal samples especially in mandibles. In addition, higher levels of VEGFR-3 in orofacial district were confirmed by western blotting analysis. We also observed that in fetal mandibular samples VEGFRs colocalized in several osteoblasts, osteoclasts and osteoprogenitor cells. Furthermore, some cells coexpressed VEGFR-3 and ET-1, a marker of neural crest cells. The results demonstrated different expression of VEGFRs in human mandibular and femoral bones which could be correlated to their different structure, function and development during organogenesis. VEGFR-3 might represent a specific signal for ectomesenchymal lineage differentiation during early human development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23059888     DOI: 10.14670/HH-27.1579

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  5 in total

Review 1.  Cabozantinib in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience.

Authors:  Jose Manuel Ruiz-Morales; Daniel Y C Heng
Journal:  Ther Adv Urol       Date:  2016-08-16

Review 2.  Targeting MET and vascular endothelial growth factor receptor signaling in castration-resistant prostate cancer.

Authors:  Richard J Lee; Matthew R Smith
Journal:  Cancer J       Date:  2013 Jan-Feb       Impact factor: 3.360

3.  Human endothelial and foetal femur-derived stem cell co-cultures modulate osteogenesis and angiogenesis.

Authors:  Stefanie Inglis; David Christensen; David I Wilson; Janos M Kanczler; Richard O C Oreffo
Journal:  Stem Cell Res Ther       Date:  2016-01-18       Impact factor: 6.832

Review 4.  Ordinary and Activated Bone Grafts: Applied Classification and the Main Features.

Authors:  R V Deev; A Y Drobyshev; I Y Bozo; A A Isaev
Journal:  Biomed Res Int       Date:  2015-11-15       Impact factor: 3.411

5.  VEGFR-2 reduces while combined VEGFR-2 and -3 signaling increases inflammation in apical periodontitis.

Authors:  Anca Virtej; Panagiota Papadakou; Hajime Sasaki; Athanasia Bletsa; Ellen Berggreen
Journal:  J Oral Microbiol       Date:  2016-09-19       Impact factor: 5.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.